Stevanato Group S.p.A. (NYSE:STVN) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Shares of Stevanato Group S.p.A. (NYSE:STVN) have received a consensus recommendation of “Moderate Buy” from the eight ratings firms that are presently covering the firm, Marketbeat reports. Four equities research analysts have rated the stock with a hold rating, two have given a buy rating and two have given a strong buy rating to the company.

A number of analysts recently issued reports on STVN shares. Weiss Ratings raised Stevanato Group from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, August 27th. Deutsche Bank Aktiengesellschaft began coverage on Stevanato Group in a research report on Wednesday. They set a “hold” rating on the stock. UBS Group began coverage on shares of Stevanato Group in a report on Wednesday, September 9th. They issued a “neutral” rating and a $23.00 price target on the stock. Finally, TD Cowen upgraded shares of Stevanato Group to a “strong-buy” rating in a research report on Wednesday, June 17th.

Stevanato Group Stock Down 0.4%

Stevanato Group stock opened at €19.36 on Thursday. Stevanato Group has a 1-year low of €12.89 and a 1-year high of €27.99. The firm has a market capitalization of $5.86 billion, a price-to-earnings ratio of 34.58, a P/E/G ratio of 1.62 and a beta of 0.78. The company has a current ratio of 1.61, a quick ratio of 1.08 and a debt-to-equity ratio of 0.21. The firm has a 50 day simple moving average of €21.08 and a 200 day simple moving average of €18.58.

Stevanato Group (NYSE:STVN) last posted its earnings results on Wednesday, August 5th. The company reported €0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of €0.15 by (€0.01). The company had revenue of €302.00 million for the quarter. Stevanato Group had a return on equity of 10.43% and a net margin of 10.99%. On average, analysts predict that Stevanato Group will post 0.69 earnings per share for the current year.

Insider Activity

In other Stevanato Group news, insider Mauro Stocchi sold 13,649 shares of the firm’s stock in a transaction on Monday, September 28th. The shares were sold at an average price of €21.50, for a total value of €293,453.50. Following the completion of the transaction, the insider directly owned 400,000 shares of the company’s stock, valued at €8,600,000. This trade represents a 3.30% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Luciano Santel sold 2,023 shares of the business’s stock in a transaction on Friday, August 7th. The shares were sold at an average price of €20.09, for a total transaction of €40,642.07. Following the transaction, the director owned 4,739 shares of the company’s stock, valued at €95,206.51. This trade represents a 29.92% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders have sold 21,926 shares of company stock valued at $459,738. 0.70% of the stock is owned by company insiders.

Institutional Investors Weigh In On Stevanato Group

Large investors have recently added to or reduced their stakes in the business. Fifth Third Bancorp increased its stake in Stevanato Group by 22.6% in the 1st quarter. Fifth Third Bancorp now owns 4,196 shares of the company’s stock worth $58,000 after acquiring an additional 773 shares during the last quarter. Integrated Wealth Concepts LLC bought a new stake in shares of Stevanato Group during the 2nd quarter valued at about $59,000. Hardy Reed LLC purchased a new position in shares of Stevanato Group during the first quarter worth about $147,000. Diversify Wealth Management LLC grew its holdings in shares of Stevanato Group by 23.9% during the first quarter. Diversify Wealth Management LLC now owns 18,353 shares of the company’s stock worth $252,000 after purchasing an additional 3,543 shares in the last quarter. Finally, First Bank & Trust grew its holdings in shares of Stevanato Group by 3.4% during the second quarter. First Bank & Trust now owns 18,417 shares of the company’s stock worth $333,000 after purchasing an additional 603 shares in the last quarter.

About Stevanato Group

Stevanato Group S.p.A. is an Italy-based provider of drug-containment, drug-delivery and diagnostic solutions for the pharmaceutical, biotechnology and healthcare industries. The company serves customers across the development, production and administration of injectable medicines, with activities spanning pharmaceutical glass packaging, medical devices and manufacturing technologies.

Its product portfolio includes glass vials, cartridges, syringes and other primary containers, as well as ready-to-use packaging solutions such as EZ-fill.